205
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Do steviol glycosides affect the oxidative and genotoxicity parameters in BALB/c mice?

ORCID Icon, ORCID Icon & ORCID Icon
Pages 464-469 | Received 16 Aug 2019, Accepted 04 Jan 2020, Published online: 21 Jan 2020

References

  • Abuhandan, M., et al., 2012. Bakteriyel menenjitli çocuklarda tedavi öncesi ve sonrası s-100b ve oksidatif durumun değerlendirilmesi. Klimik Journal, 25 (2), 16–22.
  • Barriocanal, L.A., et al., 2008. Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics. Regulatory Toxicology and Pharmacology, 51 (1), 37–41.
  • Belda-Galbis, C.M., et al., 2014. Use of the modified Gompertz equation to assess the Stevia rebaudiana Bertoni antilisterial kinetics. Food Microbiology, 38, 56–61.
  • Ceron, J.J., Tecles, F., and Tvarijonaviciute, A., 2014. Serum paraoxonase 1 (PON1) measurement: an update. BMC Veterinary Research, 10 (1), 74–81.
  • Choi, Y.H., et al., 2002. Supercritical fluid extraction and liquid chromatographic-electrospray mass spectrometric analysis of stevioside from Stevia rebaudiana leaves. Chromatographia, 55 (9–10), 617–620.
  • Das, S., et al., 1992. Evaluation of the cariogenic potential of the intense natural sweeteners stevioside and rebaudioside A. Caries Research, 26 (5), 363–366.
  • Erel, O., 2004. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Biochemistry, 37 (4), 277–285.
  • Geeraert, B., et al., 2010. Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice. International Journal of Obesity, 34 (3), 569–577.
  • Geuns, J.M., 2002. Safety evaluation of stevia and stevioside. Studies in Natural Products Chemistry, 27, 299–319.
  • Goyal, S.K., and Goyal, R.K., 2010. Stevia (Stevia rebaudiana) a bio-sweetener: a review. International Journal of Food Sciences and Nutrition, 61 (1), 1–10.
  • Gugliucci, A., and Menini, T., 2015. Paraoxonase 1 and HDL maturation. Clinica Chimica Acta, 439, 5–13.
  • Hossain, M.A., et al., 2010. Chemical composition of the essential oils of Stevia rebaudiana Bertoni leaves. Asian Journal of Traditional Medicines, 5 (2), 56–61.
  • Huxtable, R. J., 2002. Pharmacology and toxicology of stevioside, rebaudioside A, and steviol. Stevia: The Genus Stevia. London, Engl./New York (NY): Taylor and Francis; 160–177.
  • Ishidate, M., et al., 1984. Primary mutagenicity screening of food additives currently used in Japan. Food and Chemical Toxicology, 22 (8), 623–636.
  • Joint FAO/WHO Expert Committee on Food Additives. 2005. Steviol glycosides [Addendum to stevioside]. In: Safety evaluation of certain food additives: Sixtythird Meeting of the Joint FAO/WHO Expert on Food Additives, 117–144.
  • Joint FAO/WHO Expert Committee on Food Additives 2008. Steviol glycosides. In: Summary and conclusions of the 69th meeting of the joint FAO/WHO expert committee on food additives (JECFA), Rome. All Specifications Monographs from the 1st to the 65th Meeting (1956-2005). Food and Agriculture Organization of the United Nations. http://www.faoorg/ag/agn/agns/files/jecfa69_finalpdf [accessed 19 Dec 2017].
  • Khattab, S.N., et al., 2015. Production and physicochemical assessment of new stevia amino acid sweeteners from the natural stevioside. Food Chemistry, 173, 979–985.
  • Lemus-Mondaca, R., et al., 2012. Stevia rebaudiana Bertoni, source of a high-potency natural sweetener: A comprehensive review on the biochemical, nutritional and functional aspects. Food Chemistry, 132 (3), 1121–1132.
  • Lu, H., et al., 2006. Cloning, purification, and refolding of human paraoxonase-3 expressed in Escherichia coli and its characterization. Protein Expression and Purification, 46 (1), 92–99.
  • Mackness, B., et al., 2010. Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life, 62 (6), 480–482.
  • Maki, K.C., et al., 2008. Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food and Chemical Toxicology, 46 (7), S47–S53.
  • Matsui, M., et al., 1996. Evaluation of the genotoxicity of stevioside and steviol using six in vitro and one in vivo mutagenicity assays. Mutagenesis, 11 (6), 573–579.
  • Medina-Diaz, I.M., et al., 2017. Downregulation of human paraoxonase 1 (PON1) by organophosphate pesticides in HepG2 cells. Environmental Toxicology, 32 (2), 490–500.
  • Mitsuhashi, H., 1976. Safety of stevioside. In Tama Biochemical Co. Ltd. Report on Safety of Stevia, 1981, 1–2.
  • Nunes, A.P.M., et al., 2007. Analysis of genotoxic potentiality of stevioside by comet assay. Food and Chemical Toxicology, 45 (4), 662–666.
  • Özbayer, C., et al., 2011. Antioxidant and free radical-scavenging properties of Stevia rebaudiana (Bertoni) extracts and L-NNA in streptozotocine-nicotinamide induced diabetic rat liver. Turkiye Klinikleri Journal of Medical Sciences, 31 (1), 51–60.
  • Park, J.E., and Cha, Y.S., 2010. Stevia rebaudiana Bertoni extract supplementation improves lipid and carnitine profiles in C57BL/6J mice fed a high‐fat diet. Journal of the Science of Food and Agriculture, 90 (7), 1099–1105.
  • Pezzuto, J.M., et al., 1985. Metabolically activated steviol, the aglycone of stevioside, is mutagenic. Proceedings of the National Academy of Sciences, 82 (8), 2478–2482.
  • Riobó, Z.P., Sierra Poyatos, R., and Soldo Rodriguez, J., 2014. Low and no calorie sweeteners (LNCS); myths and realities. Nutricion Hospitalaria, 30, 5–9.
  • Rozek, L.S., et al., 2005. The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status. Journal of Lipid Research, 46 (9), 1888–1895.
  • Schrader, C., and Rimbach, G., 2011. Determinants of paraoxonase 1 status: genes, drugs and nutrition. Current Medicinal Chemistry, 18 (36), 5624–5643.
  • Suttajit, M., et al., 1993. Mutagenicity and human chromosomal effect of stevioside, a sweetener from Stevia rebaudiana Bertoni. Environmental Health Perspectives, 101 (3), 53–59.
  • Toyoda, K., et al., 1997. Assessment of the carcinogenicity of stevioside in F344 rats. Food and Chemical Toxicology, 35 (6), 597–603.
  • Uçar, A., et al., 2018. A research on the genotoxicity of stevia in human lymphocytes. Drug and Chemical Toxicology, 41 (2), 221–224.
  • Urban, J.D., Carakostas, M.C., and Brusick, D.J., 2013. Steviol glycoside safety: is the genotoxicity database sufficient? Food and Chemical Toxicology, 51, 386–390.
  • Williams, L.D., and Burdock, G.A., 2009. Genotoxicity studies on a high-purity rebaudioside A preparation. Food and Chemical Toxicology, 47 (8), 1831–1836.
  • Woelwer-Rieck, U., et al., 2010. Improved HPLC method for the evaluation of the major steviol glycosides in leaves of Stevia rebaudiana. European Food Research and Technology, 231 (4), 581–588.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.